Short Answer: Sequence Them, Do Not Stack Them

Federal grants and private investment are not competitors — they fund different risks, and a hardware company usually needs both. The way to get both is sequencing: use non-dilutive federal money to retire technical risk while your valuation is still low, then raise equity against the de-risked result. What breaks the combination is almost never the money itself. It is a cap table structure that makes you ineligible for the grant, a disclosure failure about overlapping funding, or timing that puts a priced round in front of the award instead of behind it. Projects House is an engineering firm, not a law firm, accounting firm, or grants consultancy; this article is educational, and eligibility, tax, and securities questions belong with your own advisors.

Why the Order Matters So Much

Non-dilutive dollars are not merely cheaper than equity dollars. They are cheaper at the moment when equity is most expensive. Early on, before a working prototype, your valuation reflects an unproven idea, so every dollar of equity buys a large slice of the company. A federal award taken at that same moment costs you no equity at all and produces exactly the artifact that raises your valuation: demonstrated feasibility.

Run the comparison honestly, though. Grants are slow, they are competitive, they constrain how money is spent, and they come with reporting overhead — see SBIR grant reporting and milestones for what that actually costs in team time. Equity is fast, flexible, and brings people who help you sell. The trade-off is laid out in grants versus investors. Most successful hardware companies use grants for the science and engineering phases and equity for the go-to-market phase.

The Eligibility Trap: Your Cap Table Can Disqualify You

This is the single most important thing to understand before you raise. SBIR and STTR eligibility depends on ownership and control, not just headcount. The core requirement is a small business concern that is more than fifty percent directly owned and controlled by individuals who are US citizens or permanent resident aliens, or by other small businesses that are themselves so owned. Some participating agencies may, under SBA authority, award to firms majority-owned by multiple venture capital operating companies, hedge funds, or private equity firms — but not all agencies participate, and the allowance is capped as a share of the agency's award dollars.

What that means in practice for a founder planning a raise:

  • Model ownership before you sign a term sheet, not after. A round that pushes institutional investors past fifty percent can end your eligibility for future awards at agencies that do not permit majority VC ownership.
  • Watch foreign ownership carefully. A foreign parent, a foreign majority holder, or foreign control arrangements can be disqualifying regardless of size.
  • Remember that convertible instruments matter eventually. A stack of SAFEs is not equity today but converts later, sometimes all at once; understand where the cap table lands post-conversion, as described in equity dilution explained.
  • Affiliation rules aggregate. Common ownership across several companies can make them affiliates for size purposes, pushing you over the employee limit even if each entity is tiny.

Read the current solicitation and the SBA size and eligibility rules for the specific agency before assuming any of this. Rules differ by agency and get updated.

No Double-Dipping: Overlap Disclosure

You may hold multiple awards and you may hold awards while investor-funded. What you may not do is get paid twice for the same work. Every proposal requires disclosure of essentially equivalent work — other pending or awarded funding for substantially the same effort, at your company or by the same key personnel elsewhere. Undisclosed overlap is treated seriously.

The clean way to hold both kinds of money is to draw a bright line through the work. Federal funds pay the research and feasibility scope in the statement of work. Investor funds pay the things federal money will not or should not: tooling, inventory, certification testing beyond the funded scope, sales, and marketing. Separate budgets, separate timekeeping, separate deliverables. That discipline also protects your IP boundary, as described in who owns the IP from a federal grant.

Where Grants Actively Help You Raise

  • Third-party validation. A competitive peer-reviewed award tells an investor that technical experts read your approach and funded it. It is not the same as commercial validation, but it removes a chunk of technical doubt from the room.
  • Better milestones for the same money. Each grant dollar spent on engineering advances the same milestones the investor cares about, so you arrive at the round with more built and less spent from the round.
  • Matching and follow-on programs. Several states and agencies offer matching funds or Phase II supplements that specifically reward attracting private capital, which turns your raise into more non-dilutive money.
  • Phase III leverage. Follow-on work derived from an SBIR project can be awarded without further competition, which is a revenue story rather than a grant story — and revenue is the best fundraising input there is. If government customers are plausible for your product, see how to sell to the government.
  • Cap table hygiene. Grants add no shareholders, no board seats, no liquidation preference, and no pro rata rights. The quiet advantage compounds over three rounds.

The Timing Mistakes People Make

  1. Waiting for grant results before starting the raise. Award cycles run months from submission to money. Run both processes in parallel and let the investor conversation mature while the proposal sits in review.
  2. Building a budget that only works if the grant lands. Assume it might not. Federal awards are competitive, and a plan with a single point of failure is not a plan — see the wider options in how to fund a hardware startup.
  3. Treating grant money as runway. It is restricted to the funded scope and often reimbursed after you spend. You still need working capital to float payroll and purchases between drawdowns.
  4. Raising a large round before the first award. The dilution is permanent and the eligibility risk is real. If the technical risk can be retired with non-dilutive money, retire it first.
  5. Letting the grant define the product. Chasing solicitation topics that do not match your commercial thesis wins money and loses the company. For where federal money fits at all, start with our government funding guide and the difference between SBIR and STTR.

A Workable Default Sequence

For a typical hardware startup: friends-and-family or founder money to reach a rough proof of concept; a Phase I award to establish feasibility with real data; an angel or pre-seed round priced against that data and a working prototype; a Phase II award to build the engineering-grade product while the round funds tooling and certification; then an institutional round against demonstrated performance and early customers. Every step in that chain buys the next step's credibility, and the equity you give up shrinks because the risk you are selling has already been retired.

Retire the Technical Risk First

Both grant reviewers and investors are buying the same thing: evidence that the technology works and the team can build it. Projects House produces that evidence — feasibility studies, working prototypes, test data, and a manufacturable design — so each funding step lands on proof rather than promises. Tell us about your project through the contact form and we will help you plan the engineering that makes both conversations easier.